{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:32:25Z","timestamp":1771471945485,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIHNS087588"],"award-info":[{"award-number":["NIHNS087588"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CJD Foundation"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiomyopathy is a co-morbidity of some prion diseases including genetic disease caused by mutations within the PrP gene (<jats:italic>PRNP<\/jats:italic>). Although the cellular prion protein (PrP) has been shown to protect against cardiotoxicity caused by oxidative stress, it is unclear if the cardiomyopathy is directly linked to PrP dysfunction. We differentiated cardiomyocyte cultures from donor human induced pluripotent stem cells and found a direct influence of the <jats:italic>PRNP<\/jats:italic> E200K mutation on cellular function. The <jats:italic>PRNP<\/jats:italic> E200K cardiomyocytes showed abnormal function evident in the irregularity of the rapid repolarization; a phenotype comparable with the dysfunction reported in Down Syndrome cardiomyocytes. <jats:italic>PRNP<\/jats:italic> E200K cardiomyocyte cultures also showed increased mitochondrial superoxide accompanied by increased mitochondrial membrane potential and dysfunction. To confirm that the changes were due to the E200K mutation, CRISPR-Cas9 engineering was used to correct the E200K carrier cells and insert the E200K mutation into control cells. The isotype matched cardiomyocytes showed that the lysine expressing allele does directly influence electrophysiology and mitochondrial function but some differences in severity were apparent between donor lines. Our results demonstrate that cardiomyopathy in hereditary prion disease may be directly linked to PrP dysfunction.<\/jats:p>","DOI":"10.1038\/s41598-022-19631-5","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T09:03:09Z","timestamp":1663837389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hereditary E200K mutation within the prion protein gene alters human iPSC derived cardiomyocyte function"],"prefix":"10.1038","volume":"12","author":[{"given":"Aleksandar R.","family":"Wood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simote T.","family":"Foliaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley R.","family":"Groveman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan O.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Quan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathryn L.","family":"Haigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"issue":"1","key":"19631_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/ajmg.b.32505","volume":"174","author":"LT Takada","year":"2017","unstructured":"Takada, L. T. et al. Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 174(1), 36\u201369 (2017).","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet."},{"issue":"322","key":"19631_CR2","first-page":"322","volume":"8","author":"EV Minikel","year":"2016","unstructured":"Minikel, E. V. et al. Quantifying prion disease penetrance using large population control cohorts. Sci. Transl. Med. 8(322), 322\u2013329 (2016).","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"19631_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/archinte.165.3.338","volume":"165","author":"ML Ashwath","year":"2005","unstructured":"Ashwath, M. L., Dearmond, S. J. & Culclasure, T. Prion-associated dilated cardiomyopathy. Arch. Internal Med. 165(3), 338\u2013340 (2005).","journal-title":"Arch. Internal Med."},{"issue":"1","key":"19631_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytz236","volume":"4","author":"O Itzhaki-Ben-Zadok","year":"2020","unstructured":"Itzhaki-Ben-Zadok, O., Orvin, K., Inbar, E. & Rechavia, E. Cardiomyopathy associated with Ceutzfeld-Jakob disease: A diagnosis of exclusion: A case report. Eur. Heart J. Case Rep. 4(1), 1\u20135 (2020).","journal-title":"Eur. Heart J. Case Rep."},{"issue":"1","key":"19631_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF01826053","volume":"1","author":"P Cortelli","year":"1991","unstructured":"Cortelli, P. et al. Cardiovascular dysautonomia in fatal familial insomnia. Clin. Auton. Res. 1(1), 15\u201321 (1991).","journal-title":"Clin. Auton. Res."},{"issue":"1","key":"19631_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.clinph.2013.06.008","volume":"125","author":"JA Palma","year":"2014","unstructured":"Palma, J. A. et al. Cardiac autonomic impairment during sleep as a marker of human prion diseases: A preliminary report. Clin. Neurophysiol. 125(1), 208\u2013210 (2014).","journal-title":"Clin. Neurophysiol."},{"issue":"5","key":"19631_CR7","doi-asserted-by":"publisher","first-page":"e97768","DOI":"10.1371\/journal.pone.0097768","volume":"9","author":"MC Garza","year":"2014","unstructured":"Garza, M. C., Monz\u00f3n, M., Mar\u00edn, B., Badiola, J. J. & Monle\u00f3n, E. Distribution of peripheral PrP(Sc) in sheep with naturally acquired scrapie. PLoS ONE 9(5), e97768 (2014).","journal-title":"PLoS ONE"},{"issue":"Pt 11","key":"19631_CR8","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1099\/vir.0.81777-0","volume":"87","author":"JE Jewell","year":"2006","unstructured":"Jewell, J. E., Brown, J., Kreeger, T. & Williams, E. S. Prion protein in cardiac muscle of elk (Cervus elaphus nelsoni) and white-tailed deer (Odocoileus virginianus) infected with chronic wasting disease. J. Gener. Virol. 87(Pt 11), 3443\u20133450 (2006).","journal-title":"J. Gener. Virol."},{"issue":"2","key":"19631_CR9","first-page":"169","volume":"51","author":"A Balachandran","year":"2010","unstructured":"Balachandran, A. et al. Experimental oral transmission of chronic wasting disease to red deer (Cervus elaphus elaphus): Early detection and late stage distribution of protease-resistant prion protein. Can. Vet. J. 51(2), 169\u2013178 (2010).","journal-title":"Can. Vet. J."},{"issue":"12","key":"19631_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028026","volume":"6","author":"RA Bessen","year":"2011","unstructured":"Bessen, R. A. et al. Transmission of chronic wasting disease identifies a prion strain causing cachexia and heart infection in hamsters. PLoS ONE 6(12), e28026 (2011).","journal-title":"PLoS ONE"},{"issue":"6","key":"19631_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039055","volume":"7","author":"GB Mitchell","year":"2012","unstructured":"Mitchell, G. B. et al. Experimental oral transmission of chronic wasting disease to reindeer (Rangifer tarandus tarandus). PLoS ONE 7(6), e39055 (2012).","journal-title":"PLoS ONE"},{"issue":"6","key":"19631_CR12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3201\/eid1906.120906","volume":"19","author":"S Krasemann","year":"2013","unstructured":"Krasemann, S. et al. BSE-associated prion-amyloid cardiomyopathy in primates. Emerg. Infect. Dis. 19(6), 985\u2013988 (2013).","journal-title":"Emerg. Infect. Dis."},{"issue":"5783","key":"19631_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.1128635","volume":"313","author":"MJ Trifilo","year":"2006","unstructured":"Trifilo, M. J. et al. Prion-induced amyloid heart disease with high blood infectivity in transgenic mice. Science (N.Y.) 313(5783), 94\u201397 (2006).","journal-title":"Science (N.Y.)"},{"issue":"2","key":"19631_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbr.2005.02.003","volume":"162","author":"PB Nico","year":"2005","unstructured":"Nico, P. B. et al. Altered behavioural response to acute stress in mice lacking cellular prion protein. Behav. Brain Res. 162(2), 173\u2013181 (2005).","journal-title":"Behav. Brain Res."},{"issue":"1","key":"19631_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neulet.2005.06.033","volume":"388","author":"PB Nico","year":"2005","unstructured":"Nico, P. B. et al. Impaired exercise capacity, but unaltered mitochondrial respiration in skeletal or cardiac muscle of mice lacking cellular prion protein. Neurosci. Lett. 388(1), 21\u201326 (2005).","journal-title":"Neurosci. Lett."},{"issue":"10","key":"19631_CR16","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0891-5849(01)00512-3","volume":"30","author":"F Klamt","year":"2001","unstructured":"Klamt, F. et al. Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radical Biol. Med. 30(10), 1137\u20131144 (2001).","journal-title":"Free Radical Biol. Med."},{"issue":"1","key":"19631_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/jnc.14281","volume":"145","author":"FH Beraldo","year":"2018","unstructured":"Beraldo, F. H. et al. Mechanisms of neuroprotection against ischemic insult by stress-inducible phosphoprotein-1\/prion protein complex. J. Neurochem. 145(1), 68\u201379 (2018).","journal-title":"J. Neurochem."},{"issue":"14","key":"19631_CR18","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/emboj.2008.122","volume":"27","author":"AS Rambold","year":"2008","unstructured":"Rambold, A. S. et al. Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J. 27(14), 1974\u20131984 (2008).","journal-title":"EMBO J."},{"issue":"3","key":"19631_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/jnr.21506","volume":"86","author":"I Dupiereux","year":"2008","unstructured":"Dupiereux, I. et al. Protective effect of prion protein via the N-terminal region in mediating a protective effect on paraquat-induced oxidative injury in neuronal cells. J. Neurosci. Res. 86(3), 653\u2013659 (2008).","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"19631_CR20","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1471-4159.2006.03906.x","volume":"98","author":"CL Haigh","year":"2006","unstructured":"Haigh, C. L. Brown, DR: Prion protein reduces both oxidative and non-oxidative copper toxicity. J. Neurochem. 98(3), 677\u2013689 (2006).","journal-title":"J. Neurochem."},{"key":"19631_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/128_2011_160","volume":"305","author":"UK Resenberger","year":"2011","unstructured":"Resenberger, U. K., Winklhofer, K. F. & Tatzelt, J. Neuroprotective and neurotoxic signaling by the prion protein. Top. Curr. Chem. 305, 101\u2013119 (2011).","journal-title":"Top. Curr. Chem."},{"issue":"9","key":"19631_CR22","doi-asserted-by":"publisher","first-page":"e25675","DOI":"10.1371\/journal.pone.0025675","volume":"6","author":"JA Turnbaugh","year":"2011","unstructured":"Turnbaugh, J. A., Westergard, L., Unterberger, U., Biasini, E. & Harris, D. A. The N-terminal, polybasic region is critical for prion protein neuroprotective activity. PLoS ONE 6(9), e25675 (2011).","journal-title":"PLoS ONE"},{"issue":"9","key":"19631_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136923","volume":"10","author":"B Zhang","year":"2015","unstructured":"Zhang, B. et al. Prion protein protects against renal ischemia\/reperfusion injury. PLoS ONE 10(9), e0136923 (2015).","journal-title":"PLoS ONE"},{"issue":"3","key":"19631_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.etp.2009.12.004","volume":"63","author":"H Zocche-Soprana","year":"2011","unstructured":"Zocche-Soprana, H., Canes-Souza, L., Debbas, V. & Martins Laurindo, F. R. Cellular prion protein (PrP(C)) and superoxide dismutase (SOD) in vascular cells under oxidative stress. Exp. Toxicol. Pathol. 63(3), 229\u2013236 (2011).","journal-title":"Exp. Toxicol. Pathol."},{"issue":"1","key":"19631_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/cvr\/cvu194","volume":"104","author":"F Zanetti","year":"2014","unstructured":"Zanetti, F. et al. The cellular prion protein counteracts cardiac oxidative stress. Cardiovasc. Res. 104(1), 93\u2013102 (2014).","journal-title":"Cardiovasc. Res."},{"key":"19631_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.nbd.2018.11.003","volume":"124","author":"G Keller","year":"2019","unstructured":"Keller, G., Binyamin, O., Frid, K., Saada, A. & Gabizon, R. Mitochondrial dysfunction in preclinical genetic prion disease: A target for preventive treatment?. Neurobiol. Dis. 124, 57\u201366 (2019).","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"19631_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10557-017-6735-0","volume":"31","author":"S Casini","year":"2017","unstructured":"Casini, S., Verkerk, A. O. & Remme, C. A. Human iPSC-derived cardiomyocytes for investigation of disease mechanisms and therapeutic strategies in inherited arrhythmia syndromes: Strengths and limitations. Cardiovasc. Drugs Therapy 31(3), 325\u2013344 (2017).","journal-title":"Cardiovasc. Drugs Therapy"},{"issue":"6","key":"19631_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.stem.2020.05.004","volume":"26","author":"E Giacomelli","year":"2020","unstructured":"Giacomelli, E. et al. Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease. Cell Stem Cell 26(6), 862-879.e811 (2020).","journal-title":"Cell Stem Cell"},{"key":"19631_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fphys.2018.00080","volume":"9","author":"JT Koivum\u00e4ki","year":"2018","unstructured":"Koivum\u00e4ki, J. T. et al. Structural immaturity of human iPSC-derived cardiomyocytes: In silico investigation of effects on function and disease modeling. Front. Physiol. 9, 80 (2018).","journal-title":"Front. Physiol."},{"issue":"24","key":"19631_CR30","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1038\/emboj.2013.240","volume":"32","author":"M Bellin","year":"2013","unstructured":"Bellin, M. et al. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. EMBO J. 32(24), 3161\u20133175 (2013).","journal-title":"EMBO J."},{"key":"19631_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ijms19113583","volume":"19","author":"M Paci","year":"2018","unstructured":"Paci, M., Casini, S., Bellin, M., Hyttinen, J. & Severi, S. Large-scale simulation of the phenotypical variability induced by loss-of-function long QT mutations in human induced pluripotent stem cell cardiomyocytes. Int. J. Mol. Sci. 19, 11 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"19631_CR32","doi-asserted-by":"publisher","first-page":"101901","DOI":"10.1016\/j.scr.2020.101901","volume":"47","author":"S Rebs","year":"2020","unstructured":"Rebs, S., Sedaghat-Hamedani, F., Kayvanpour, E., Meder, B. & Streckfuss-B\u00f6meke, K. Generation of pluripotent stem cell lines and CRISPR\/Cas9 modified isogenic controls from a patient with dilated cardiomyopathy harboring a RBM20 p.R634W mutation. Stem Cell Res. 47, 101901 (2020).","journal-title":"Stem Cell Res."},{"issue":"5","key":"19631_CR33","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/stem.1961","volume":"33","author":"A Bosman","year":"2015","unstructured":"Bosman, A. et al. Perturbations of heart development and function in cardiomyocytes from human embryonic stem cells with trisomy 21. Stem Cells (Dayton, Ohio) 33(5), 1434\u20131446 (2015).","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"19631_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/pathogens9060482","volume":"9","author":"ST Foliaki","year":"2020","unstructured":"Foliaki, S. T. et al. Pathogenic prion protein isoforms are not present in cerebral organoids generated from asymptomatic donors carrying the E200K mutation associated with familial prion disease. Pathogens 9, 6 (2020).","journal-title":"Pathogens"},{"key":"19631_CR35","first-page":"5","volume":"2021","author":"S Baiardi","year":"2021","unstructured":"Baiardi, S. et al. Phenotypic diversity of genetic Creutzfeldt-Jakob disease: A histo-molecular-based classification. Acta Neuropathol. 2021, 5 (2021).","journal-title":"Acta Neuropathol."},{"issue":"Pt 3","key":"19631_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1099\/vir.0.007930-0","volume":"90","author":"EA Asante","year":"2009","unstructured":"Asante, E. A. et al. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J. Gen. Virol. 90(Pt 3), 546\u2013558 (2009).","journal-title":"J. Gen. Virol."},{"issue":"1","key":"19631_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13041-021-00864-w","volume":"14","author":"ST Foliaki","year":"2021","unstructured":"Foliaki, S. T. et al. Neuronal excitatory-to-inhibitory balance is altered in cerebral organoid models of genetic neurological diseases. Mol. Brain 14(1), 156 (2021).","journal-title":"Mol. Brain"},{"issue":"2","key":"19631_CR38","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1006\/bbrc.2002.6460","volume":"291","author":"G Miele","year":"2002","unstructured":"Miele, G., Jeffrey, M., Turnbull, D., Manson, J. & Clinton, M. Ablation of cellular prion protein expression affects mitochondrial numbers and morphology. Biochem. Biophys. Res. Commun. 291(2), 372\u2013377 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"19631_CR39","doi-asserted-by":"publisher","first-page":"41556","DOI":"10.1038\/srep41556","volume":"7","author":"R Faris","year":"2017","unstructured":"Faris, R. et al. Cellular prion protein is present in mitochondria of healthy mice. Sci. Rep. 7, 41556 (2017).","journal-title":"Sci. Rep."},{"issue":"1","key":"19631_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-020-00915-8","volume":"8","author":"IH Fl\u00f8nes","year":"2020","unstructured":"Fl\u00f8nes, I. H. et al. Mitochondrial respiratory chain deficiency correlates with the severity of neuropathology in sporadic Creutzfeldt-Jakob disease. Acta Neuropathol. Commun. 8(1), 50 (2020).","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"19631_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1471-4159.2007.05123.x","volume":"105","author":"AW Paterson","year":"2008","unstructured":"Paterson, A. W., Curtis, J. C. & Macleod, N. K. Complex I specific increase in superoxide formation and respiration rate by PrP-null mouse brain mitochondria. J. Neurochem. 105(1), 177\u2013191 (2008).","journal-title":"J. Neurochem."},{"issue":"8","key":"19631_CR42","first-page":"1247","volume":"1837","author":"M Forkink","year":"2014","unstructured":"Forkink, M. et al. Mitochondrial hyperpolarization during chronic complex I inhibition is sustained by low activity of complex II, III, IV and V. Biochem. Biophys. Acta. 1837(8), 1247\u20131256 (2014).","journal-title":"Biochem. Biophys. Acta."},{"issue":"10","key":"19631_CR43","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1074\/jbc.M210432200","volume":"278","author":"N Li","year":"2003","unstructured":"Li, N. et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 278(10), 8516\u20138525 (2003).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"19631_CR44","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/jnnp-2018-318756","volume":"89","author":"A Poleggi","year":"2018","unstructured":"Poleggi, A. et al. Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by the CYP4X1 gene. J. Neurol. Neurosurg. Psychiatry 89(12), 1243\u20131249 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"19631_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1101\/cshperspect.a019505","volume":"8","author":"SB Baylin","year":"2016","unstructured":"Baylin, S. B. & Jones, P. A. Epigenetic determinants of cancer. Cold Spring Harb. Perspect. Biol. 8, 9 (2016).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"19631_CR46","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2741\/4847","volume":"25","author":"S Ilango","year":"2020","unstructured":"Ilango, S., Paital, B., Jayachandran, P., Padma, P. R. & Nirmaladevi, R. Epigenetic alterations in cancer. Front. Biosci. (Landmark Ed.) 25, 1058\u20131109 (2020).","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"19631_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jocn.2019.04.015","volume":"66","author":"E Mitrov\u00e1","year":"2019","unstructured":"Mitrov\u00e1, E. et al. Genetic Creutzfeldt-Jakob disease affected monozygotic twins: Analysis of survival time, age at death and possible exogenous risk factors. J. Clin. Neurosci. 66, 191\u2013195 (2019).","journal-title":"J. Clin. Neurosci."},{"issue":"2","key":"19631_CR48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/1531-8249(200002)47:2<257::AID-ANA20>3.0.CO;2-U","volume":"47","author":"ES Simon","year":"2000","unstructured":"Simon, E. S. et al. Creutzfeldt-Jakob disease profile in patients homozygous for the PRNP E200K mutation. Ann. Neurol. 47(2), 257\u2013260 (2000).","journal-title":"Ann. Neurol."},{"issue":"1","key":"19631_CR49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-019-0742-2","volume":"7","author":"BR Groveman","year":"2019","unstructured":"Groveman, B. R. et al. Sporadic creutzfeldt-jakob disease prion infection of human cerebral organoids. Acta Neuropathol. Commun. 7(1), 90 (2019).","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"19631_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074377","volume":"8","author":"DM Henderson","year":"2013","unstructured":"Henderson, D. M. et al. Rapid antemortem detection of CWD prions in deer saliva. PLoS ONE 8(9), e74377 (2013).","journal-title":"PLoS ONE"},{"key":"19631_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/v8050140","volume":"8","author":"CD Orr\u00fa","year":"2016","unstructured":"Orr\u00fa, C. D. et al. Factors that improve RT-QuIC detection of prion seeding activity. Viruses 8, 5 (2016).","journal-title":"Viruses"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19631-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19631-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19631-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T10:22:25Z","timestamp":1663842145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19631-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19631"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19631-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15788"}}